Literature DB >> 7815261

The acid steatocrit: a much improved method.

M Tran1, P Forget, A Van den Neucker, J Strik, B van Kreel, R Kuijten.   

Abstract

The steatocrit method has recently been introduced as a simple screening test for steatorrhea. As it seemed likely that separation of fecal homogenate by centrifugation into a lipid phase, a watery phase, and a solid phase would be pH-dependent, we evaluated the effect of fecal acidification on steatocrit results. We also compared classical and acid steatocrit results in healthy children and in patients with cystic fibrosis and studied the relationship between two steatocrit methods and fecal fat content as measured by a reference chemical method. Steatocrit results increased with the degree of fecal acidification, and maximal results were obtained at the lowest fecal pH values. Means and SEM for classical and acid steatocrit values were 1.1 +/- 0.4% (classical) versus 3.8 +/- 1% (acid) in controls (n = 6) and 5.4 +/- 1.9% (classical) versus 26.9 +/- 4.3% (acid) in cystic fibrosis patients (n = 9). The correlations between fecal fat content measured chemically and steatocrit results were 0.18 (p = 0.35) and 0.81 (p < 0.0001) for classical and acid steatocrit, respectively. We conclude that acidification of fecal homogenates leads to a marked improvement in the steatocrit method.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7815261     DOI: 10.1097/00005176-199410000-00007

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  14 in total

Review 1.  Control of malabsorption in cystic fibrosis.

Authors:  J M Littlewood; S P Wolfe
Journal:  Paediatr Drugs       Date:  2000 May-Jun       Impact factor: 3.022

2.  Fecal elastase1 and acid steatocrit estimation in chronic pancreatitis.

Authors:  Banavara Narasimhamurthy Girish; Gopalakrishna Rajesh; Kannan Vaidyanathan; Vallath Balakrishnan
Journal:  Indian J Gastroenterol       Date:  2010-02-23

3.  Fat malabsorption in cystic fibrosis: comparison of quantitative fat assay and a novel assay using fecal lauric/behenic acid.

Authors:  Jill Dorsey; Donna Buckley; Suzanne Summer; Ronald J Jandacek; Therese Rider; Patrick Tso; Michael R Narkewicz; James E Heubi
Journal:  J Pediatr Gastroenterol Nutr       Date:  2010-04       Impact factor: 2.839

4.  Carotenoid coloration is related to fat digestion efficiency in a wild bird.

Authors:  Christina Madonia; Pierce Hutton; Mathieu Giraudeau; Tuul Sepp
Journal:  Naturwissenschaften       Date:  2017-10-28

5.  The steatocrit as a measure of fecal fat excretion: uses and pitfalls.

Authors:  B S Ramakrishna
Journal:  Indian J Gastroenterol       Date:  2009-12

6.  Lipid, nitrogen, water and energy content of a single stool sample in healthy children and children with cystic fibrosis.

Authors:  Anita Maria Van den Neucker; Pierre-Philippe Forget; Bernard van Kreel
Journal:  Eur J Pediatr       Date:  2003-08-27       Impact factor: 3.183

7.  Increased energy expenditure, dietary fat wasting, and resistance to diet-induced obesity in mice lacking renin.

Authors:  Nobuyuki Takahashi; Feng Li; Kunjie Hua; Jianbei Deng; Chih-Hong Wang; Robert R Bowers; Timothy J Bartness; Hyung-Suk Kim; Joyce B Harp
Journal:  Cell Metab       Date:  2007-12       Impact factor: 27.287

8.  Characteristics of multi-organ lymphangiectasia resulting from temporal deletion of calcitonin receptor-like receptor in adult mice.

Authors:  Samantha L Hoopes; Helen H Willcockson; Kathleen M Caron
Journal:  PLoS One       Date:  2012-09-17       Impact factor: 3.240

9.  Simple and noninvasive method for assessment of digestive efficiency: Validation of fecal steatocrit in greenfinch coccidiosis model.

Authors:  Richard Meitern; Mari-Ann Lind; Ulvi Karu; Peeter Hõrak
Journal:  Ecol Evol       Date:  2016-11-17       Impact factor: 2.912

10.  Diagnosing malabsorption with systemic lipid profiling: pharmacokinetics of pentadecanoic acid and triheptadecanoic acid following oral administration in healthy subjects and subjects with cystic fibrosis.

Authors:  Virginia A Stallings; John T Mondick; Joan I Schall; Jeffrey S Barrett; Martha Wilson; Maria R Mascarenhas
Journal:  Int J Clin Pharmacol Ther       Date:  2013-04       Impact factor: 1.366

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.